FIELD: medicine.
SUBSTANCE: method involves prescribing a drug therapy comprising administering Tamsulosin, selective alpha-1-adrenoreceptor blocking agent in tablets, orally in a dose of 40 mg with a meal once a day; it is combined with M-cholinomimetic neostigmine methylsulphate injected subcutaneously in 0.05% solution 1 ml that makes a daily dose of 0.5 mg once a day, 6 hours after administering Tamsulosin, selective alpha-1-adrenoreceptor blocking agent. The lithokinetic therapy following the presented schedule is conducted for 1 to 7 days in the period of which calculi are removed from the ureter.
EFFECT: method enables providing more effective calculi removal from the ureter, reducing the length of treatment, reducing the need for surgical manipulations and the number of complications.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ENDOSCOPIC TREATMENT OF PATIENTS WITH NEPHROLITHIASIS USING ALPHA-BLOCKERS | 2021 |
|
RU2779496C1 |
| UROLITHIASIS TREATMENT MODE | 2008 |
|
RU2360679C1 |
| METHOD OF TREATING PATIENTS WITH CALCULI IN LOWER ONE-THIRD OF URETERS | 2014 |
|
RU2564146C1 |
| METHOD FOR PERFORMING TRANSURETHRAL URETERONEPHROLITHOTRIPSY AND URETERONEPHROLITHOEXTRACTION WITH FUNCTIONALLY NARROWED URETERAL LUMEN | 2021 |
|
RU2757531C2 |
| METHOD OF TREATING DISEASES COMPLICATED BY ORGAN HYPOTONIA AND ATONIA ACCOMPANYING DIABETES MELLITUS | 2012 |
|
RU2538693C2 |
| METHOD FOR REHABILITATION OF PATIENTS SUFFERING UROLITHIASIS FOLLOWING LITHOTRIPSY | 2012 |
|
RU2492881C1 |
| METHOD FOR TREATING THE CASES OF UROLITHIASIS | 1999 |
|
RU2143879C1 |
| METHOD FOR INTRAOPERATIVE DETERMINATION OF INTRAPELVIC PRESSURE IN PERCUTANEOUS LITHOTRIPSY IN PATIENTS WITH UROLITHIASIS | 2022 |
|
RU2788282C1 |
| METHOD OF TREATING NEPHROLITHIASIS PATIENTS WITH DENSE STONES | 2018 |
|
RU2687593C1 |
| METHOD OF SURGICAL MINIMALLY INVASIVE TREATMENT OF NEPHROLITHIASIS IN ADULTS | 2018 |
|
RU2689853C2 |
